Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Oral ulceration: an unusual manifestation of lymphomatoid granulomatosis.

Kidoguchi K, Yoshimura M, Kojima K, Ureshino H, Egashira R, Yokoo M, Kai K, Egashira Y, Ohshima K, Ando T, Kimura S.

Ann Hematol. 2018 Oct 3. doi: 10.1007/s00277-018-3506-3. [Epub ahead of print] No abstract available.

PMID:
30284019
2.

Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.

Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Kimura S.

Ann Hematol. 2019 Feb;98(2):465-471. doi: 10.1007/s00277-018-3502-7. Epub 2018 Sep 27.

PMID:
30264165
3.

Treatment Choice for Primary Rectal MALT lymphoma.

Ureshino H, Ito Y.

QJM. 2018 Sep 12. doi: 10.1093/qjmed/hcy206. [Epub ahead of print] No abstract available.

PMID:
30215790
4.

Sustained ventricular tachycardia caused by subacute thyroiditis.

Narita K, Ureshino H, Hashimoto S.

Intern Med J. 2018 Sep;48(9):1160-1162. doi: 10.1111/imj.14018. No abstract available.

PMID:
30182396
5.

Rectal MALT lymphoma regression and anti-Helicobacter pylori therapy.

Ito Y, Ureshino H, Tsuruoka N, Noda T.

QJM. 2018 Oct 1;111(10):737-738. doi: 10.1093/qjmed/hcy144. No abstract available.

PMID:
29961825
6.

Allelic Polymorphisms of KIRs and HLAs Predict Favorable Responses to Tyrosine Kinase Inhibitors in CML.

Ureshino H, Shindo T, Kojima H, Kusunoki Y, Miyazaki Y, Tanaka H, Saji H, Kawaguchi A, Kimura S.

Cancer Immunol Res. 2018 Jun;6(6):745-754. doi: 10.1158/2326-6066.CIR-17-0462. Epub 2018 Apr 25.

PMID:
29695383
7.

Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia.

Shindo T, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, Kimura S.

Oncoimmunology. 2017 Dec 11;7(3):e1405204. doi: 10.1080/2162402X.2017.1405204. eCollection 2018.

8.

Primary effusion lymphoma-like lymphoma with a T cell phenotype.

Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefor AK, Matsuishi E.

Ann Hematol. 2018 Apr;97(4):717-718. doi: 10.1007/s00277-017-3200-x. Epub 2017 Dec 4. No abstract available.

PMID:
29199356
9.

Three coexisting lymphomas in a single patient: composite lymphoma derived from a common germinal center B-cell precursor and unrelated discordant lymphoma.

Nishioka A, Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Itamura H, Kubota Y, Kojima K, Ohshima K, Kimura S.

Int J Hematol. 2018 Jun;107(6):703-708. doi: 10.1007/s12185-017-2370-6. Epub 2017 Nov 25.

PMID:
29177642
10.

Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Ureshino H, Ando T, Kizuka H, Kusaba K, Sano H, Nishioka A, Itamura H, Shindo T, Kubota Y, Kojima K, Kimura S.

Hematol Oncol. 2018 Feb;36(1):324-327. doi: 10.1002/hon.2481. Epub 2017 Oct 3.

PMID:
28971493
11.

Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement.

Akutagawa T, Shindo T, Yamanouchi K, Hayakawa M, Ureshino H, Tsuruoka N, Sakata Y, Shimoda R, Noguchi R, Furukawa K, Morita S, Iwakiri R, Kimura S, Matsumoto M, Fujimoto K.

Intern Med. 2017 Sep 15;56(18):2431-2433. doi: 10.2169/internalmedicine.8603-16. Epub 2017 Aug 21.

12.

Paraneoplastic Sarcoidosis in Multiple Myeloma.

Kusaba K, Kojima K, Naito S, Taba M, Kai K, Ureshino H, Nishida Y, Kimura S.

Intern Med. 2017;56(15):2049-2051. doi: 10.2169/internalmedicine.56.8331. Epub 2017 Aug 1.

13.

Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients.

Ureshino H, Kamachi K, Miyahara M.

Ann Hematol. 2017 Sep;96(9):1587-1588. doi: 10.1007/s00277-017-3052-4. Epub 2017 Jun 27. No abstract available.

PMID:
28656327
14.

Chronic myeloid leukemia and NK cell immunity.

Ureshino H, Shindo T, Tanaka H, Kimura S.

Rinsho Ketsueki. 2017;58(4):381-388. doi: 10.11406/rinketsu.58.381. Japanese.

PMID:
28484170
15.

Steroid-Refractory Autoimmune Hemolytic Anemia with Massive Splenomegaly.

Ureshino H, Miyahara M.

Am J Med. 2017 Sep;130(9):e393-e394. doi: 10.1016/j.amjmed.2017.03.017. Epub 2017 Apr 5. No abstract available.

PMID:
28389309
16.

5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).

Ureshino H, Kizuka H, Kusaba K, Sano H, Nishioka A, Shindo T, Kubota Y, Ando T, Kojima K, Kimura S.

Int J Hematol. 2017 May;105(5):692-696. doi: 10.1007/s12185-016-2160-6. Epub 2016 Dec 2. Review.

PMID:
27914067
17.

The correlation between FDG uptake and biological molecular markers in pancreatic cancer patients.

Kaida H, Azuma K, Kawahara A, Yasunaga M, Kitasato Y, Hattori S, Taira T, Ureshino H, Kage M, Ishii K, Murakami T, Ishibashi M.

Eur J Radiol. 2016 Oct;85(10):1804-1810. doi: 10.1016/j.ejrad.2016.08.007. Epub 2016 Aug 10.

PMID:
27666620
18.

Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.

Ureshino H, Nishioka A, Kojima K, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.

Intern Med. 2016;55(18):2703-6. doi: 10.2169/internalmedicine.55.6966. Epub 2016 Sep 15.

19.

Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma.

Ureshino H, Nishioka A, Kojima K, Suzuki M, Kizuka H, Sano H, Shindo T, Kubota Y, Ando T, Kimura S.

Intern Med. 2016;55(15):2061-4. doi: 10.2169/internalmedicine.55.6140. Epub 2016 Aug 1.

20.

Unusual co-occurrence of Evans syndrome and pure red cell aplasia in elderly patient with prostate cancer.

Ureshino H, Miyahara M.

Ann Hematol. 2016 Oct;95(10):1743-4. doi: 10.1007/s00277-016-2750-7. Epub 2016 Jul 28. No abstract available.

PMID:
27465154
21.

Acute Megakaryoblastic Leukemia with Myelodysplasia-related Changes Associated with ATM Gene Deletion.

Ureshino H, Tanabe M, Kurogi K, Miyahara M, Kimura S.

Intern Med. 2016;55(12):1625-9. doi: 10.2169/internalmedicine.55.5890. Epub 2016 Jun 15.

22.

Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia.

Ureshino H, Shindo T, Nishikawa H, Watanabe N, Watanabe E, Satoh N, Kitaura K, Kitamura H, Doi K, Nagase K, Kimura H, Samukawa M, Kusunoki S, Miyahara M, Shin-I T, Suzuki R, Sakaguchi S, Kimura S.

Cancer Immunol Res. 2016 Aug;4(8):644-9. doi: 10.1158/2326-6066.CIR-15-0303. Epub 2016 May 23.

23.

Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.

Ureshino H, Miyahara M.

Ann Hematol. 2016 Apr;95(5):841-3. doi: 10.1007/s00277-016-2624-z. Epub 2016 Feb 29. No abstract available.

PMID:
26923458
24.

Rituximab-containing Chemotherapy (R-CHOP)-induced Kaposi's Sarcoma in an HIV-negative Patient with Diffuse Large B Cell Lymphoma.

Ureshino H, Ando T, Kojima K, Itamura H, Jinnai S, Doi K, Ohshima K, Kurogi K, Miyahara M, Kimura S.

Intern Med. 2015;54(24):3205-8. doi: 10.2169/internalmedicine.54.5103. Epub 2015 Dec 15.

25.

Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.

Ureshino H, Kadota C, Kurogi K, Miyahara M, Kimura S.

Intern Med. 2015;54(17):2235-9. doi: 10.2169/internalmedicine.54.4207. Epub 2015 Sep 1.

26.

Protective Effect of Nitric Oxide on Liver Circulation from Ischemia Reperfusion Injury.

Toshihiro W, Kurata S, Takuro S, Ichiro O, Yasuaki S, Ikeda T, Ureshino H, Ayuse T.

J Invest Surg. 2015;28(5):236-44. doi: 10.3109/08941939.2015.1024357. Epub 2015 Aug 20.

PMID:
26290958
27.

N-myc downstream-regulated gene 1 promotes tumor inflammatory angiogenesis through JNK activation and autocrine loop of interleukin-1α by human gastric cancer cells.

Murakami Y, Watari K, Shibata T, Uba M, Ureshino H, Kawahara A, Abe H, Izumi H, Mukaida N, Kuwano M, Ono M.

J Biol Chem. 2013 Aug 30;288(35):25025-37. doi: 10.1074/jbc.M113.472068. Epub 2013 Jul 11.

28.

Y-box binding protein-1 contributes to both HER2/ErbB2 expression and lapatinib sensitivity in human gastric cancer cells.

Shibata T, Kan H, Murakami Y, Ureshino H, Watari K, Kawahara A, Kage M, Hattori S, Ono M, Kuwano M.

Mol Cancer Ther. 2013 May;12(5):737-46. doi: 10.1158/1535-7163.MCT-12-1125. Epub 2013 Feb 27.

29.

Milrinone and levosimendan administered after reperfusion improve myocardial stunning in swine.

Shibata I, Cho S, Yoshitomi O, Ureshino H, Maekawa T, Hara T, Sumikawa K.

Scand Cardiovasc J Suppl. 2013 Feb;47(1):50-7. doi: 10.3109/14017431.2012.732236. Epub 2012 Oct 10.

PMID:
22994851
30.

N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition.

Ureshino H, Murakami Y, Watari K, Izumi H, Kawahara A, Kage M, Arao T, Nishio K, Yanagihara K, Kinoshita H, Kuwano M, Ono M.

PLoS One. 2012;7(7):e41312. doi: 10.1371/journal.pone.0041312. Epub 2012 Jul 23.

31.

Direct protective effects of dexmedetomidine against myocardial ischemia-reperfusion injury in anesthetized pigs.

Yoshitomi O, Cho S, Hara T, Shibata I, Maekawa T, Ureshino H, Sumikawa K.

Shock. 2012 Jul;38(1):92-7. doi: 10.1097/SHK.0b013e318254d3fb.

PMID:
22552015
32.

Nuclear expression of N-myc downstream regulated gene 1/Ca(2+)-associated protein 43 is closely correlated with tumor angiogenesis and poor survival in patients with gastric cancer.

Kawahara A, Akiba J, Hattori S, Yamaguchi T, Abe H, Taira T, Ureshino H, Murakami Y, Watari K, Koufuji K, Shirouzu K, Kuwano M, Ono M, Kage M.

Exp Ther Med. 2011 May;2(3):471-479. Epub 2011 Mar 2.

33.

Effects of nitric oxide donor on hepatic arterial buffer response in anesthetized pigs.

Ayuse T, Mishima K, Oi K, Ureshino H, Sumikawa K.

J Invest Surg. 2010 Aug;23(4):183-9. doi: 10.3109/08941931003596885.

PMID:
20690842
34.

Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells.

Murakami Y, Hosoi F, Izumi H, Maruyama Y, Ureshino H, Watari K, Kohno K, Kuwano M, Ono M.

Biochem Biophys Res Commun. 2010 May 28;396(2):376-81. doi: 10.1016/j.bbrc.2010.04.100. Epub 2010 Apr 21.

PMID:
20416281
35.

Perioperative challenges associated with a pancreaticoduodenectomy and distal pancreatectomy for pancreatic cancer in patients with situs inversus totalis: report of two cases.

Maruyama Y, Horiuchi H, Okabe Y, Kawahara R, Uchida S, Sakai T, Hisaka T, Ishikawa H, Mikagi K, Yoshitomi M, Kawashima Y, Fujishita M, Akasu G, Katsumoto M, Eto D, Ureshino M, Goto Y, Ureshino H, Kinoshita H.

Surg Today. 2010;40(1):79-82. doi: 10.1007/s00595-009-4064-z. Epub 2009 Dec 29.

PMID:
20037847
36.

Synthetic atrial natriuretic peptide improves systemic and splanchnic circulation and has a lung-protective effect during endotoxemia in pigs.

Sekino M, Makita T, Ureshino H, Sungsam C, Sumikawa K.

Anesth Analg. 2010 Jan 1;110(1):141-7. doi: 10.1213/ANE.0b013e3181c4ee6c. Epub 2009 Nov 21.

PMID:
19933537
37.

Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway.

Matsumoto S, Cho S, Tosaka S, Ureshino H, Maekawa T, Hara T, Sumikawa K.

Cardiovasc Drugs Ther. 2009 Aug;23(4):263-70. doi: 10.1007/s10557-009-6184-5.

PMID:
19597978
38.

Multi-centric pancreatic cancer without PanIN lesion.

Naito Y, Eriguchi N, Kume T, Naito M, Nishimura M, Ohdo M, Itai N, Hayashida S, Naito H, Arikawa S, Ureshino H, Yasumoto M, Kusano H, Yano H.

J Hepatobiliary Pancreat Surg. 2009;16(5):699-703. doi: 10.1007/s00534-009-0065-y. Epub 2009 Mar 31.

PMID:
19333539
39.

Usefulness of lavage cytology during endoscopic transpapillary catheterization into the gallbladder in the cytological diagnosis of gallbladder disease.

Naito Y, Okabe Y, Kawahara A, Taira T, Isida Y, Kaji R, Sata M, Ureshino H, Mikagi K, Kinoshita H, Yasumoto M, Kusano H, Kage M, Yano H.

Diagn Cytopathol. 2009 Jun;37(6):402-6. doi: 10.1002/dc.21013.

PMID:
19191298
40.

Administration of the Rho-kinase inhibitor fasudil before ischemia or just after reperfusion, but not 30 min after reperfusion, protects the stunned myocardium in swine.

Shibata I, Yoshitomi O, Use T, Ureshino H, Cho S, Maekawa T, Hara T, Sumikawa K.

Cardiovasc Drugs Ther. 2008 Aug;22(4):293-8. doi: 10.1007/s10557-008-6106-y. Epub 2008 May 10.

PMID:
18470606
41.

Cardioprotection induced by olprinone, a phosphodiesterase III inhibitor, involves phosphatidylinositol-3-OH kinase-Akt and a mitochondrial permeability transition pore during early reperfusion.

Tosaka S, Makita T, Tosaka R, Maekawa T, Cho S, Hara T, Ureshino H, Sumikawa K.

J Anesth. 2007;21(2):176-80. Epub 2007 May 30.

PMID:
17458647
42.

Milrinone administered before ischemia or just after reperfusion, attenuates myocardial stunning in anesthetized swine.

Use T, Makita T, Ureshino H, Cho S, Yoshitomi O, Akiyama D, Oshibuchi M, Hara T, Sumikawa K.

Cardiovasc Drugs Ther. 2006 Oct;20(5):327-34.

PMID:
17119877
43.

The interaction of MCI-154, a calcium sensitizer, and isoflurane on systemic and coronary hemodynamics in chronically instrumented dogs.

Takahashi S, Cho S, Hara T, Ureshino H, Tomiyasu S, Sumikawa K.

Anesth Analg. 2004 Jan;98(1):30-6, table of contents.

PMID:
14693578
44.

Hemodynamic interactions of propofol and dantrolene in chronically instrumented dogs.

Cho S, Zhang S, Ureshino H, Hara T, Tomiyasu S, Sumikawa K.

Anesth Analg. 2003 May;96(5):1369-73, table of contents.

PMID:
12707135
45.

Interaction of isoflurane and cromakalim, a KATP channel opener, on coronary and systemic haemodynamics in chronically instrumented dogs.

Sakai K, Zhang S, Ureshino H, Tomiyasu S, Sumikawa K.

Acta Anaesthesiol Scand. 2000 Oct;44(9):1122-7.

PMID:
11028734
46.

Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil.

Zhang S, Sakai K, Hasuo H, Furuta K, Ureshino H, Shibata O, Sumikawa K.

Res Commun Mol Pathol Pharmacol. 1999;105(1-2):115-27.

PMID:
10850375
47.

Comparative analysis of systemic and coronary hemodynamics during sevoflurane- and isoflurane-induced hypotension in dogs.

Tomiyasu S, Hara T, Hasuo H, Ureshino H, Sumikawa K.

J Cardiovasc Pharmacol. 1999 May;33(5):741-7.

PMID:
10226861

Supplemental Content

Loading ...
Support Center